iNeuMab™ Mouse Anti-Human Cytokeratin-19 Monoclonal Antibody (CBP2276)

Name: iNeuMab™ Mouse Anti-Human Cytokeratin-19 Monoclonal Antibody (CBP2276)
SKU: NAB2010205LS
Rating: 5 (1 reviews)

[CAT#: NAB2010205LS]

Anti-Tubulin Beta 3 (TUBB3) Antibody

Host Species:: Mouse

Species Reactivity:: Human

Applications:: WB; ICC

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Request Pricing

Inquiry

Product Overview

Immunogen

Fusion protein

Species Reactivity

Human

Clonality

Monoclonal

Host Species

Mouse

Isotype

IgG2a, κ

Clone Number

CBP2276

Applications

WB; ICC

Relevant Diseases

Brain Tumors; Alzheimer's Disease; Parkinson's Disease; Neurocutaneous Syndromes

Research Areas

Neuroinflammation

Conjugation

Unconjugated; APC; PE; HRP; Biotin; FITC

Product Properties

Form

Liquid

Formulation

PBS, pH 7.2, containing 0.09% sodium azide.

Concentration

0.5 mg/mL

Purification

Affinity chromatography

Purity

>95%, as determined by Coomassie stained SDS-PAGE.

Endotoxin Level

Low Endotoxin

Shipping

The product is shipped at 4°C. Upon receipt, store it immediately at the recommended temperature.

Storage

Store at -20°C. Upon initial thawing, apportion into working aliquots and store at -20°C. Avoid repeated freeze-thaw cycles to prevent denaturing the antibody.

Handling Advice

Store at -20°C. Upon initial thawing, apportion into working aliquots and store at -20°C. Avoid repeated freeze-thaw cycles to prevent denaturing the antibody.

Research Use Only

For research use only, not for diagnostic or therapeutic use.

Target

Cytokeratin 19

Official Name

KRT19

Full Name

Keratin, type I cytoskeletal 19

Alternative Names

KRT19; CK19; K19; K1CS; keratin 19

Gene ID

3880 (Human); 16669 (Mouse)

Uniprot ID

P08727 (Human); P19001 (Mouse)

References

1. Katsetos CD, et al. 2003. J. Child Neurol. 18:851.
2. Mobarakeh ZT, et al. 2012. Cell Biol. Int. Rep. (2010) 19:e00015.
3. Locher H, et al. 2013. Differentiation. 85:173.
4. Karki R, et al. 2013. Expert Opin. Ther. Targets. 17:461.
5. Mariani M, et al. 2011. Curr. Mol. Med. 11:726.
6. Koh Y, et al. 2009. Ann. Oncol. 20:1414.

Publications